|
|
The Hidden Danger Dangers of Hepatitis B
by Rebecca B. Mammo, MD, MPH
It's Sunday, right after
a church sermon. The smell of frankincense was still lingering
in the air when the priest pulled me to the side and asked for
my advice about a 21-year-old Ethiopian
woman who had been losing weight drastically over the last few
weeks. She was complaining of severe right upper side abdominal
pain, nausea, loss of appetite, and had yellowish hue in her eyes
and skin (jaundice). In the same town, an Ethiopian nursing student
had been by the bedside of her severely ill 59-year-old father.
This man raised ten children with great family values and had
provided the best education available in Ethiopia. However, he
was slowly succumbing to a liver disease he rarely suspected.
Both case narratives are based
on true stories, and underscore the devastating impact of hepatitis
B on the Ethiopian community. Approximately 2 billion people worldwide
have chronic hepatitis B. In Ethiopia, it is estimated that 7.3
million (11%) people are chronic hepatitis B carriers. There is
no specific data I could obtain on hepatitis B infection amongst
Ethiopians in America, nevertheless this disease poses a major
health problem in the United States. According to the Center for
Disease Control and Prevention (CDC), nearly 1.5 million people
in the United States have chronic hepatitis B. About 25 to 40%
of those who are carriers of hepatitis B develop liver disease
such as cirrhosis (scarred liver) and a specific type of liver
cancer known as hepatocellular carcinoma - the case in point of
the 59-year-old father. A smaller proportionof 1% develops deadly
acute hepatitis, as did the 21-year-old young woman.
How is hepatitis B transmitted?
The mode of hepatitis B transmission is very similar to that
of HIV. The virus is concentrated in the greatest amounts of blood,
vaginal secretion, and semen. Sex without condoms among heterosexuals
and vertical (mother-to-fetus)transmission comprise the two leading
modes of infection. Hepatitis B can also be contracted through
needle sharing, ear piercing, tattooing, sharing razors and toothbrush
as well as use of contaminated surgical equipments, including
ones used for female circumcision in Ethiopia. Hepatitis B is
different from hepatitis A - an acute self-limited infection secondary
to unsanitary food handling and contaminated water. Hepatitis
C causes chronic liver disease and is more likely to be transmitted
through contaminated blood (IV drug needle, blood transfusion)
and less likely
through sexual intercourse. Currently, there is no vaccine for
hepatitis C.
Health practitioners generally
screen for hepatitis B infection with the clinical history, hepatitis
B surface antigen (HBsAg), which is a marker of infection, and
two antibodies: IgM anti-HBc, marker for acute infection and IgG
anti-HBc, marker for chronic infection. In my practice, I usually
check for immunity against hepatitis B rendered by vaccination
by measuring
the level of antibodies against the hepatitis B surface antigen
(anti-HBS) one to six months after vaccination, for adults, and
three to nine months, for infants. This is because a small
percentage (10%) of those vaccinated do not develop immunity after
vaccination and may require repeat vaccination. In stark contrast
to HIV, there is a highly effective vaccination that can prevent
hepatitis B transmission.
Currently, CDC mandates that
all infants, health care professionals, and high-risk populations
receive three recommended hepatitis B immunizations. The designation
of 'high risk' includes those at risk of sexual exposure
to the virus, IV drug users, renal dialysis patients and hemophiliacs.
CDC also recommends that all pregnant women be screened for hepatitis
B surface antigen (HBsAg) as part of their prenatal care. Each
year, approximately 150,000 infants are born to women who have
immigrated to the United States from areas of the world where
hepatitis B virus infection is highly endemic, which includes
Ethiopia. If an expecting mother tests positive, her newborn will
automatically receive HBIG post-exposure passive immunization
in the nursery to prevent risk of infection.
In summary, hepatitis B is a
deadly but preventable disease of the liver, an organ with many
vital functions including detoxification of the body of deadly
toxins, inhibition of uncontrolled bleeding after surgeries or
accidents as well as provision of key ingredients for digestion
of fats and elimination of waste. I especially recommend that
young people who are sexually active get screened and/or vaccinated
with the hepatitis B vaccine, which is effective, safe and
available at most health centers. Only then, we can prevent unnecessary
loss of life to hepatitis B.
|
|
About
Rebecca B. Mammo
Dr. Rebecca B. Mammo is a
graduate of Harvard Medical School and is currently the Director
of Ujima Hollistic Family Health Center in
Oakland, California.
| |